Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice

Toxicology Letters

Volumn 147, Issue 1, 2004, Pages 87-94

  Osuchowski, Marcin F ^a   Johnson, Victor J ^a,b   He, Quanren ^a   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Brain amines; Dopamine; Mice; Myriocin; Serotonin; Sphingolipids; SPT

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; BRAIN AMINE; DOPAMINE; HOMOVANILLIC ACID; NEUROTRANSMITTER; NORADRENALIN; SERINE PALMITOYLTRANSFERASE; SEROTONIN; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; THERMOZYMOCIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; LIPOGENESIS; LIVER; MEDULLA OBLONGATA; MESENCEPHALON; MOUSE; NERVOUS SYSTEM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

EID: 0347683383     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.10.016     Document Type: Article

References (39)

1. Bagli J.F., Kluepfel D., Stjacque M. Elucidation of structure and stereochemistry of myriocin - novel antifungal antibiotic. J. Org. Chem. 38:1973;1253-1260.
2. Berthoud H.R., Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 85:2000;1-17.
3. Brownie C.F., Cullen J. Characterization of experimentally induced equine leukoencephalomalacia (ELEM) in ponies (Equus caballus): preliminary report. Vet. Hum. Toxicol. 29:1987;34-38.
4. Bucci L.R. Selected herbals and human exercise performance. Am. J. Clin. Nutr. 72:2000;624S-636S.
5. Cho Y.J., Park J.P., Hwang H.J., Kim S.W., Choi J.W., Yun J.W. Production of red pigment by submerged culture of Paecilomyces sinclairii. Lett. Appl. Microbiol. 35:2002;195-202.
6. Dantzer R., Konsman J.P., Bluthe R.M., Kelley K.W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton. Neurosci. 85:2000;60-65.
7. Erickson J.T., Millhorn D.E. Hypoxia and electrical stimulation of the carotic sinus nerve induce Fos-like immunoreactivity within catecholaminergic and serotoninergic neurons of the rat brain stem. J. Comp. Neurol. 348:1994;161-182.
8. Ferguson A.V., Bains J.S. Electrophysiology of the circumventricular organs. Front. Neuroendocrinol. 17:1996;440-475.
9. Fujita T., Yoneta M., Hirose R. Simple compounds, 2-alkyl-2-amino-1,3- propanediols have potent immunosuppressive activity. Bio. Med. Chem. Lett. 5:1995;847-852.
10. Fujita T., Inoue K., Yamamoto S., Ikumoto T., Sasaki S., Toyama R., Chiba K., Hoshino Y., Okumoto T. Fungal metabolites. II. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J. Antibiot. 47:1994;208-215.
11. Furuya S., Mitoma J., Makino A., Hirabayashi Y. Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. J. Neurochem. 71:1998;366-377.
12. Ganong W.F. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 27:2000;422-427.
13. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine. J. Neurochem. 13:1966;655-669.
14. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience. 111:2002;815-835.
15. Hadjiconstantinou M., Yates A.J., Neff N.H. Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside. J. Neurochem. 55:1990;864-869.
16. He, Q., Johnson, V.J., Osuchowski, M.F., Sharma, R.P., 2004. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver. Mycopathologia, in press.
17. He Q., Riley R.T., Sharma R.P. Fumonisin-induced tumor necrosis factor a expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition. Toxicol. Appl. Pharmacol. 174:2001;69-77.
18. He Q., Riley R.T., Sharma R.P. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo. Pharmacol. Toxicol. 90:2002;268-277.
19. Hannun Y.A., Obeid L.M. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277:2002;25847-25850.
20. Hering H., Lin C., Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23:2003;3262-3271.
21. Im D.S. Linking Chinese medicine and G-protein-coupled receptors. Trends Pharmacol. Sci. 24:2003;2-4.
22. Jentsch J.D., Roth R.H., Taylor J.R. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog. Brain. Res. 126:2000;433-453.
23. Kinney H.C., Karthigasan J., Borenshteyn N.I., Flax J.D., Kirschner D.A. Myelination in the developing human brain - biochemical correlates. Neurochem. Res. 19:1994;983-996.
24. Kozutsumi Y., Kanazawa T., Sun Y., Yamaji T., Yamamoto H., Takematsu H. Sphingolipids involved in the induction of multinuclear cell formation. Biochim. Biophys. Acta. 1582:2002;138-143.
25. Levade T., Auge N., Veldman R.J., Cuvillier O., Negre-Salvayre A., Salvayre R. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ. Res. 89:2001;957-968.
26. Merrill A.H. Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem. 277:2002;25843-25846.
27. Merrill A.H. Jr., Wang E., Mullins R.E., Jamison W.C., Nimkar S., Liotta D.C. Quantitation of free sphingosine in liver by high-performance liquid chromatograph. Anal. Biochem. 171:1988;373-381.
28. Miyake Y., Kozutsumi Y., Nakamura S., Fujita T., Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem. Biophys. Res. Commun. 211:1995;396-403.
29. Nakamura S., Kozutsumi Y., Sun Y.D., Miyake Y., Fujita T., Kawasaki T. Dual roles of sphingolipids in signaling of the escape from and onset of apoptosis in a mouse cytotoxic T-cell line, CTLL-2. J. Biol. Chem. 271:1996;1255-1257.
30. Napoli K.L. The FTY720 story. Ther. Drug. Monit. 22:2000;47-51.
31. Richerson G.B., Wang W., Tiwari J., Bradley S.R. Chemosensitivity of serotonergic neurons in the rostral ventral medulla. Respir. Physiol. 129:2001;175-189.
32. Schneider J.S., DiStefano L. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in murine model of parkinsonism. Neurology. 44:1994;748-750.
33. Shigemori M., Okamoto Y., Watanabe T., Kuramoto S. Effects of monosialoganglioside (GM1) on transected monoaminergic pathways. J. Neurotrauma. 7:1990;89-97.
34. Smith W.L., Merrill A.H. Sphingolipid metabolism and signaling minireview series. J. Biol. Chem. 277:2002;25841-25842.
35. Spiegel S., Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277:2002;25851-25854.
36. Tsunoda M., Johnson V.J., Sharma R.P. Increase in dopamine metabolites in murine striatum after oral exposure to inorganic but not organic form of selenium. Arch. Environ. Contam. Toxicol. 39:2000;32-37.
37. Williams R.D., Wang E., Merril A.H. Enzymology of long-chain base synthesis by liver-characterization of serine palmitoyltransferase in rat-liver microsomes. Arch. Biochem. Biophys. 228:1984;282-291.
38. van Meer G., Lisman Q. Sphingolipid transport: rafts and translocators. J. Biol. Chem. 277:2002;25855-25858.
39. Yang Z., Chen M., Fialkow L.B., Ellett J.D., Wu R., Brinkmann V., Nadler J.L., Lynch K.R. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice small star, filled. Clin Immunol. 107:2003;30-35.